Atomistry » Fluorine » PDB 3nlz-3og7 » 3og7
Atomistry »
  Fluorine »
    PDB 3nlz-3og7 »
      3og7 »

Fluorine in PDB 3og7: B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032

Enzymatic activity of B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032

All present enzymatic activity of B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032:
2.7.11.1;

Protein crystallography data

The structure of B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032, PDB code: 3og7 was solved by Y.Zhang, K.Y.Zhang, C.Zhang, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 21.30 / 2.45
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 50.770, 104.424, 110.128, 90.00, 90.00, 90.00
R / Rfree (%) 21.3 / 25.8

Other elements in 3og7:

The structure of B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032 also contains other interesting chemical elements:

Chlorine (Cl) 1 atom

Fluorine Binding Sites:

The binding sites of Fluorine atom in the B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032 (pdb code 3og7). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032, PDB code: 3og7:
Jump to Fluorine binding site number: 1; 2;

Fluorine binding site 1 out of 2 in 3og7

Go back to Fluorine Binding Sites List in 3og7
Fluorine binding site 1 out of 2 in the B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1

b:33.0
occ:1.00
F25 A:0321 0.0 33.0 1.0
C24 A:0321 1.3 34.8 1.0
C23 A:0321 2.3 24.6 1.0
C18 A:0321 2.4 35.4 1.0
C17 A:0321 2.8 34.1 1.0
C16 A:0321 3.2 37.8 1.0
C15 A:0321 3.2 37.5 1.0
O19 A:0321 3.6 44.0 1.0
C22 A:0321 3.6 29.6 1.0
C20 A:0321 3.6 26.2 1.0
CB A:ALA481 3.6 44.4 1.0
CB A:LYS483 3.9 30.8 1.0
CG1 A:VAL471 3.9 52.8 1.0
OG1 A:THR529 4.0 36.0 1.0
N A:LYS483 4.0 36.1 1.0
C A:ALA481 4.0 39.3 1.0
O A:ALA481 4.0 36.7 1.0
C21 A:0321 4.1 27.3 1.0
CG2 A:VAL471 4.2 41.2 1.0
C A:VAL482 4.2 35.5 1.0
N A:VAL482 4.2 40.0 1.0
C05 A:0321 4.3 42.7 1.0
N14 A:0321 4.3 34.9 1.0
CA A:LYS483 4.3 31.2 1.0
CA A:ALA481 4.4 31.9 1.0
O A:ILE527 4.5 37.1 1.0
CB A:VAL471 4.6 47.2 1.0
CA A:VAL482 4.6 34.1 1.0
CG2 A:THR529 4.7 31.0 1.0
O A:VAL482 4.7 35.0 1.0
F26 A:0321 4.7 41.1 1.0
C06 A:0321 4.9 40.7 1.0
CG A:LYS483 4.9 33.6 1.0
CB A:THR529 4.9 31.8 1.0

Fluorine binding site 2 out of 2 in 3og7

Go back to Fluorine Binding Sites List in 3og7
Fluorine binding site 2 out of 2 in the B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX4032 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1

b:41.1
occ:1.00
F26 A:0321 0.0 41.1 1.0
C20 A:0321 1.3 26.2 1.0
C18 A:0321 2.4 35.4 1.0
C21 A:0321 2.4 27.3 1.0
N27 A:0321 2.7 36.6 1.0
C17 A:0321 2.8 34.1 1.0
O19 A:0321 3.0 44.0 1.0
N A:ASP594 3.5 49.2 1.0
O A:HOH44 3.5 50.8 1.0
CE1 A:PHE583 3.6 54.1 1.0
C24 A:0321 3.6 34.8 1.0
C22 A:0321 3.6 29.6 1.0
CD2 A:LEU514 3.6 35.3 1.0
CZ A:PHE583 3.7 55.4 1.0
C16 A:0321 3.8 37.8 1.0
C A:GLY593 3.9 63.3 1.0
CA A:GLY593 4.0 59.8 1.0
CA A:ASP594 4.1 34.5 1.0
CB A:ASP594 4.1 53.7 1.0
C23 A:0321 4.1 24.6 1.0
C15 A:0321 4.4 37.5 1.0
S28 A:0321 4.4 52.0 1.0
F25 A:0321 4.7 33.0 1.0
O A:GLY593 4.7 69.0 1.0
CD1 A:PHE583 4.8 63.9 1.0
CG A:ASP594 4.8 76.6 1.0
NZ A:LYS483 4.8 32.4 1.0
C05 A:0321 4.9 42.7 1.0
CE2 A:PHE583 4.9 66.8 1.0
CE A:LYS483 5.0 32.7 1.0

Reference:

G.Bollag, P.Hirth, J.Tsai, J.Zhang, P.N.Ibrahim, H.Cho, W.Spevak, C.Zhang, Y.Zhang, G.Habets, E.A.Burton, B.Wong, G.Tsang, B.L.West, B.Powell, R.Shellooe, A.Marimuthu, H.Nguyen, K.Y.Zhang, D.R.Artis, J.Schlessinger, F.Su, B.Higgins, R.Iyer, K.D'andrea, A.Koehler, M.Stumm, P.S.Lin, R.J.Lee, J.Grippo, I.Puzanov, K.B.Kim, A.Ribas, G.A.Mcarthur, J.A.Sosman, P.B.Chapman, K.T.Flaherty, X.Xu, K.L.Nathanson, K.Nolop. Clinical Efficacy of A Raf Inhibitor Needs Broad Target Blockade in Braf-Mutant Melanoma. Nature V. 467 596 2010.
ISSN: ISSN 0028-0836
PubMed: 20823850
DOI: 10.1038/NATURE09454
Page generated: Mon Jul 14 18:18:29 2025

Last articles

F in 7G5Q
F in 7G5P
F in 7G5M
F in 7G5C
F in 7G5I
F in 7G5H
F in 7G55
F in 7G4Y
F in 7G5B
F in 7G54
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy